메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Sanchit Sharma (All India Institute of Medical Sciences) Arti Gupta (All India Institute of Medical Sciences) Saurabh Kedia (All India Institute of Medical Sciences) Samagra Agarwal (All India Institute of Medical Sciences) Namrata Singh (All India Institute of Medical Sciences) Sandeep Goyal (All India Institute of Medical Sciences) Saransh Jain (All India Institute of Medical Sciences) Vipin Gupta (All India Institute of Medical Sciences) Pabitra Sahu (All India Institute of Medical Sciences) Sudheer Kumar Vuyyuru (All India Institute of Medical Sciences) Bhaskar Kante (All India Institute of Medical Sciences) Raju Sharma (All India Institute of Medical Sciences New Delhi) Rajesh Panwar (All India Institute of Medical Sciences) Peush Sahni (All India Institute of Medical Sciences) Govind Makharia (All India Institute of Medical Sciences) Vineet Ahuja (All India Institute of Medical Sciences)
저널정보
대한장연구학회 Intestinal research Intestinal research Vol.19 No.3
발행연도
2021.1
수록면
291 - 300 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India.Methods: This was a retrospective analysis of CD patients who received EEN as a sole modality/adjunct to other treatment. The primary and secondary outcomes changed in Crohn’s Disease Activity Index (CDAI), and clinical response (decline in CDAI > 70), respectively, at 4 and 8 weeks. Subgroup analysis evaluated response across different phenotypes, EEN formulations and prior treatment. Linear mixed effect model was created to assess the predictors of EEN response.Results: Thirty-one CD patients received EEN over median duration of 4 weeks (range, 2–6 weeks). CDAI showed a significant improvement post EEN at 4 (baseline 290 [260–320] vs. 240 [180–280], <i>P</i>= 0.001) and 8 weeks (baseline 290 [260–320] vs. 186 [160–240], <i>P</i>= 0.001), respectively. The cumulative clinical response rates at 4 and 8 weeks were 37.3% and 80.4% respectively. The clinical response rates at 8 weeks across B1 (n = 4), B2 (n = 18) and B3 (n = 9) phenotypes were 50%, 78.8% and 100% respectively (log-rank test, <i>P</i>= 0.093). The response rates at 8 weeks with polymeric (n = 8) and semi-elemental diet (n = 23) were 75% and 82.6%% respectively (log-rank test, <i>P</i>= 0.49). Baseline CDAI (odds ratio, 1.008; 95% confidence interval, 1.002–1.017; <i>P</i>= 0.046) predicted response to EEN.Conclusions: EEN was effective in inducing clinical response across different phenotypes of CD. Baseline disease activity remained the most important predictor of clinical response to EEN.

목차

등록된 정보가 없습니다.

참고문헌 (37)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0